GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $21,554,000 | +41.3% | 186,760 | +19.2% | 0.02% | +25.0% |
Q3 2020 | $15,252,000 | -50.9% | 156,670 | -41.9% | 0.01% | -63.6% |
Q3 2019 | $31,043,000 | -59.0% | 269,865 | -38.5% | 0.03% | -56.0% |
Q2 2019 | $75,671,000 | +17.6% | 438,955 | +15.0% | 0.08% | +17.2% |
Q1 2019 | $64,351,000 | +28.2% | 381,745 | -25.9% | 0.06% | +14.3% |
Q4 2018 | $50,183,000 | -21.5% | 515,281 | +39.2% | 0.06% | -5.1% |
Q3 2018 | $63,923,000 | -3.7% | 370,054 | -22.2% | 0.06% | -9.2% |
Q2 2018 | $66,398,000 | +9.5% | 475,833 | -11.6% | 0.06% | +8.3% |
Q1 2018 | $60,649,000 | -6.2% | 538,293 | +9.9% | 0.06% | -6.2% |
Q4 2017 | $64,670,000 | +29.4% | 489,890 | -0.5% | 0.06% | +25.5% |
Q3 2017 | $49,982,000 | +1.6% | 492,480 | +0.4% | 0.05% | -1.9% |
Q2 2017 | $49,195,000 | -12.8% | 490,721 | +5.2% | 0.05% | -14.8% |
Q1 2017 | $56,400,000 | +237.8% | 466,345 | +212.1% | 0.06% | +221.1% |
Q4 2016 | $16,698,000 | -15.5% | 149,419 | +0.3% | 0.02% | -9.5% |
Q3 2016 | $19,771,000 | +177.3% | 148,958 | +91.3% | 0.02% | +162.5% |
Q2 2016 | $7,131,000 | -59.4% | 77,871 | -59.5% | 0.01% | -55.6% |
Q3 2015 | $17,574,000 | -36.1% | 192,343 | -14.1% | 0.02% | -28.0% |
Q2 2015 | $27,492,000 | -0.8% | 223,805 | -26.4% | 0.02% | 0.0% |
Q1 2015 | $27,721,000 | +58.2% | 304,196 | +17.5% | 0.02% | +56.2% |
Q4 2014 | $17,523,000 | -18.1% | 258,914 | +29.9% | 0.02% | -20.0% |
Q2 2014 | $21,385,000 | +89.0% | 199,316 | +4.6% | 0.02% | +81.8% |
Q1 2014 | $11,314,000 | – | 190,573 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|